- Treating impaired cognition in schizophreniaH M Ibrahim
Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX 75390 9086, USA
Curr Pharm Biotechnol 13:1587-94. 2012..In addition, we propose that not only pharmacological, but also psychological treatments should be considered to enhance cognition in schizophrenia...
- Schizophrenia: treatment targets beyond monoamine systemsHisham M Ibrahim
Department of Psychiatry, University of Texas Southwestern, Dallas, 75390 9086, USA
Annu Rev Pharmacol Toxicol 51:189-209. 2011..Animal models, some with genetic characteristics, can be more easily and directly developed to match an individual component than to match an illness definition as broad as schizophrenia...
- Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatientsA John Rush
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
Neuropsychopharmacology 30:405-16. 2005..Global patient ratings such as the PGI-I, as opposed to specific item-based ratings, provide less valid findings...